ORIGINAL ARTICLEPerformance of Risk Indices for Identifying Low Bone Density in Postmenopausal Women
Section snippets
Data Collection
The original study to develop the SCORE tool recruited community-dwelling women 45 years and older during the years 1994 to 1995.8 Women were recruited from various offices, including family practice, general medicine, rheumatology, endocrinology, and gynecology offices. In each office, the first 10 to 15 women seen for routine checkup or follow-up were recruited. Patients were excluded if they had anatomy that prevented measurement of spine or hip BMD and if they had metabolic bone disease
RESULTS
The 1102 women from the US clinic sample used in this analysis ranged in age from 45 to 87 years, with a mean of 61 years (Table 1). Other characteristics used in the analyses are shown in Table 1. The prevalence of osteoporosis based on femoral neck BMD increased with age (Figure 1). For example, the proportion of women with T scores of -2.5 or less at the femoral neck increased from approximately 5% (24/527) in those younger than 60 years to 42% (22/52) in those 80 years and older.
The
DISCUSSION
Although most physicians and patients are aware of osteoporosis, it is being diagnosed and appropriately treated in only a small proportion of patients; this is true even for patients who have already had fractures.3, 4, 23, 24 Physicians should consider the evaluation of postmenopausal patients to be a higher priority if we are to curtail the growing tide of fractures that is already a substantial socioeconomic problem in developed countries. Risk indices based on easily obtained information
REFERENCES (34)
- et al.
Construction of an algorithm for quick detection of patients with low bone mineral density and its applicability in daily general practice
J Clin Epidemiol
(2000) - et al.
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
Lancet
(1996) - et al.
Performance of osteoporosis risk indices in a Japanese population
Curr Ther Res Clin Exp
(2001) - et al.
Likelihood ratios with confidence: sample size estimation for diagnostic test studies
J Clin Epidemiol
(1991) - et al.
Discordance in patient classification using T-scores
J Clin Densitom
(1999) - et al.
The Canadian SCORE questionnaire: optimizing the use of technology for low bone density assessment
J Clin Densitom
(2000) - et al.
Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in a sample of white women from Belgium
Bone
(2001) - et al.
Guide lines for diagnosis and management of osteoporosis: the European Foundation for Osteoporosis and Bone Disease
Osteoporos Int
(1997) Physician's Guide to Prevention and Treatment of Osteoporosis
(1998)How Fragile is Her Future?
(2000)
Osteoporosis: risk factor prevalence and drug and densitometry utilization [abstract]
Obstet Gynecol
Predictors of bone mass in perimenopausal women: a prospective study of clinical data using photon absorptiometry
Ann Intern Med
Assessment of the risk of post-menopausal osteoporosis using clinical factors
Clin Endocrinol
Factors associated with appendicular bone mass in older women
Ann Intern Med
Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density
Am J Manag Care
Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry
CMAJ
SOFSURF: a simple, useful risk factor system can identify the large majority of women with osteoporosis [abstract]
Bone
Cited by (132)
Risk assessment tools for osteoporosis and fractures in 2022
2022, Best Practice and Research: Clinical RheumatologyUtility of Osteoporosis Self-Assessment Tool as a Screening Tool for Osteoporosis in Irish Men and Women: Results of the DXA-HIP Project
2021, Journal of Clinical DensitometryMachine Learning Can Improve Clinical Detection of Low BMD: The DXA-HIP Study
2021, Journal of Clinical DensitometryCitation Excerpt :The OSTi has been demonstrated as a simple efficient method for identifying those with low BMD, and we have shown similar results in a large group of Irish men and women. While some studies included subjects with prior fractures (19,23,26,42), we chose to exclude patients with prior fracture, as “low BMD” belongs to one of several important risk factors for while “fracture” is the consequence. Here we focus on identifying patients with low BMD who may be at a high risk of future fracture.
Who should be screened for osteoporosis?
2020, Marcus and Feldman’s OsteoporosisBone Health and Survival in Women With Multiple Myeloma
2018, Clinical Lymphoma, Myeloma and Leukemia
- 1
Drs Ross, Melton, and Byrnes and Ms Turpin are employees of Merck & Co, Inc, and own stock options.